IL6 and Insulin resistance: The reduction in adipose tissue decreases the release of proinflammatory adipokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which contribute to a low-grade systemic inflammation and insulin resistance [61].